MGP
TECH icon

Metis Global Partners’s Bio-Techne TECH Stock Holding History

Metis Global Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+2,918
New +$158K ﹤0.01% 680
2025
Q2 		– Sell
-8,193
Closed -$480K – 809
2025
Q1 		$480K Buy
8,193
+1,281
+19% +$86.8K 0.01% 599
2024
Q4 		$498K Buy
6,912
+265
+4% +$19.5K 0.02% 588
2024
Q3 		$531K Buy
6,647
+226
+4% +$17K 0.02% 561
2024
Q2 		$460K Buy
6,421
+42
+0.7% +$3.09K 0.02% 555
2024
Q1 		$449K Sell
6,379
-27
-0.4% -$1.93K 0.02% 577
2023
Q4 		$494K Sell
6,406
-452
-7% -$29.8K 0.02% 552
2023
Q3 		$467K Buy
6,858
+941
+16% +$74.3K 0.02% 540
2023
Q2 		$483K Buy
5,917
+724
+14% +$58.2K 0.03% 524
2023
Q1 		$385K Buy
5,193
+1,648
+46% +$127K 0.02% 539
2022
Q4 		$294K Buy
+3,545
New +$282K 0.03% 530
2022
Q3 		– Sell
-2,464
Closed -$214K – 547
2022
Q2 		$214K Sell
2,464
-24
-1% -$2.25K 0.03% 493
2022
Q1 		$269K Buy
+2,488
New +$257K 0.03% 457

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Metis Global Partners's TECH Position: Q2 2026 in Review

Metis Global Partners opened a new position in Bio-Techne (TECH) in Q2 2026: 2,918 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #680 among its holdings. This is a return to the name: Metis Global Partners previously reported a position in TECH as recently as Q1 2025.

Metis Global Partners first reported a position in TECH in Q1 2022 and has held it in 13 quarters since. The position peaked at $531K in Q3 2024. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Metis Global Partners held 2,918 shares of Bio-Techne worth $206K as of Q2 2026.
  • Bio-Techne was a new Metis Global Partners position in Q2 2026.
  • Bio-Techne made up ﹤0.01% of Metis Global Partners's portfolio in Q2 2026, its #680 holding.
  • Metis Global Partners first reported a position in Bio-Techne in Q1 2022 and has held it in 13 quarters since.
  • Metis Global Partners's Bio-Techne position peaked at $531K in Q3 2024.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.